N-Terminal peptidic boronic acids selectively inhibit human ClpXP

被引:29
作者
Knott, Kenneth [1 ]
Fishovitz, Jennifer [2 ]
Thorpe, Steven B. [1 ]
Lee, Irene [2 ]
Santos, Webster L. [1 ]
机构
[1] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA
[2] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
关键词
ATP-DEPENDENT PROTEASE; ALPHA; BETA-UNSATURATED CARBONYL-COMPOUNDS; CATALYZED BETA-BORATION; LON PROTEASE; ESCHERICHIA-COLI; ANTIFUNGAL AGENT; TRANSITION-STATE; CHYMOTRYPSIN; DEGRADATION; POTENT;
D O I
10.1039/c004247a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis and development of N-terminal peptidic boronic acids as protease inhibitors is reported. N-Terminal peptidic boronic acids interrogate the S' sites of the target protein for selectivity and provide a new strategy that complements the currently known peptidic alpha-amino boronic acids (C-terminal boronic acids). After screening a series of N-terminal peptidic boronic acids, the first selective inhibitor of human ClpXP, an ATP-dependent serine protease present in the mitochondrial matrix, was discovered. This should facilitate the understanding of the physiological function of this protease
引用
收藏
页码:3451 / 3456
页数:6
相关论文
共 31 条
[1]   Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids [J].
Adams, J ;
Behnke, M ;
Chen, SW ;
Cruickshank, AA ;
Dick, LR ;
Grenier, L ;
Klunder, JM ;
Ma, YT ;
Plamondon, L ;
Stein, RL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (04) :333-338
[2]   Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis [J].
Baker, Stephen J. ;
Zhang, Yong-Kang ;
Akama, Tsutomu ;
Lau, Agnes ;
Zhou, Huchen ;
Hernandez, Vincent ;
Mao, Weimin ;
Alley, M. R. K. ;
Sanders, Virginia ;
Plattner, Jacob J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) :4447-4450
[3]   Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders [J].
Bota, DA ;
Davies, KJA .
MITOCHONDRION, 2001, 1 (01) :33-49
[4]   Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion [J].
Bulteau, AL ;
Lundberg, KC ;
Ikeda-Saito, M ;
Isaya, G ;
Szweda, LI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :5987-5991
[5]   Identification of the proteasome inhibitor MG262 as a potent ATP-dependent inhibitor of the Salmonella enterica serovar typhimurium lon protease [J].
Frase, Hilary ;
Hudak, Jason ;
Lee, Irene .
BIOCHEMISTRY, 2006, 45 (27) :8264-8274
[6]   sp2-sp3 Hybridized Mixed Diboron: Synthesis, Characterization, and Copper-Catalyzed β-Boration of α,β-Unsaturated Conjugated Compounds [J].
Gao, Ming ;
Thorpe, Steven B. ;
Santos, Webster L. .
ORGANIC LETTERS, 2009, 11 (15) :3478-3481
[7]  
GARCIANAFRIA J, 2010, PROTEIN SCI
[8]   Characterization of peptidyl boronic acid inhibitors of mammalian 20 S and 26 S proteasomes and their inhibition of proteasomes in cultured cells [J].
Gardner, RC ;
Assinder, SJ ;
Christie, G ;
Mason, GGF ;
Markwell, R ;
Wadsworth, H ;
McLaughlin, M ;
King, R ;
Chabot-Fletcher, MC ;
Breton, JJ ;
Allsop, D ;
Rivett, AJ .
BIOCHEMICAL JOURNAL, 2000, 346 :447-454
[9]  
GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350
[10]   N-heterocyclic carbenes([+]): Generation under mild conditions and formation of group 8-10 transition metal complexes relevant to catalysis [J].
Herrmann, WA ;
Elison, M ;
Fischer, J ;
Kocher, C ;
Artus, GRJ .
CHEMISTRY-A EUROPEAN JOURNAL, 1996, 2 (07) :772-780